Jefferies International Limited. Result of Placing in Banca Farmafactoring (6065O)
02 June 2020 - 4:00PM
UK Regulatory
TIDM0RON
RNS Number : 6065O
Jefferies International Limited.
02 June 2020
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES,
CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION
WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF
THAT JURISDICTION
PRESS RELEASE
Successful completion of the accelerated bookbuild offering
launched by BFF Luxembourg S.à r.l. in Banca Farmafactoring
S.p.A.
The proceeds amount to EUR88.4 million, deriving from the sale
of 17 million existing ordinary shares of Banca Farmafactoring
S.p.A., at a price of EUR5.20 per share.
Luxembourg - 02 June 2020 . Further to the press release
published on 01 June 2020, BFF Luxembourg S.à r.l. ("BFF Lux")
announces the successful completion of the accelerated bookbuild
offering (the "Placement") of existing ordinary shares of Banca
Farmafactoring S.p.A. ("BFF" or the "Company"). In particular, BFF
Lux announces the placement to institutional investors of
17,000,000 existing ordinary shares in BFF, equal to approximately
10% of the Company's issued share capital as of the date of this
press release, at a price of
EUR5.20 per share.
The settlement of the Placement will take place on 04 June
2020.
Gross proceeds of the Placement amount to EUR88.4 million.
After completion of the Placement, BFF Lux continues to hold a
stake in BFF of 11.9% of the Company's share capital.
Jefferies International Limited acted as sole bookrunner of the
Placement (the "Sole Bookrunner").
BFF Lux has agreed, in line with the market practice, to a
60-day lock-up period from the closing of the Placement with
respect to sales of any remaining shares it holds in BFF. Subject
to customary exceptions substantially in line with those already
agreed in the context of BFF's initial public offering, no
additional sales of shares of BFF will be made by BFF Lux during
the lock-up period without the prior consent of the Sole
Bookrunner.
Rothschild & Co acted as financial advisor of BFF Lux.
The Company will not receive any proceeds from the
Placement.
* * *
This announcement is not for publication, distribution or
release, directly or indirectly, in or into the United States of
America (including its territories and possessions, any state of
the United States and the District of Columbia), Canada, South
Africa, Australia or Japan or any other jurisdiction where such an
announcement would be unlawful. The distribution of this
announcement may be restricted by law in certain jurisdictions and
persons into whose possession this document or other information
referred to herein comes should inform themselves about and observe
any such restriction. Any failure to comply with these restrictions
may constitute a violation of the securities laws of any such
jurisdiction.
The securities referred to herein have not been and will not be
registered under the U.S. Securities Act of 1933, as amended, and
may not be offered or sold in the United States without
registration thereunder or pursuant to an available exemption
therefrom. Neither this document nor the information contained
herein constitutes or forms part of an offer to sell, or the
solicitation of an offer to buy, securities in the United States.
There will be no public offer of any securities in the United
States or in any other jurisdiction.
In any EEA Member State, this communication is only addressed to
and is only directed at qualified investors in that Member State
within the meaning of Article 2(e) of Regulation (EU) 2017/1129
(the "Prospectus Regulation"). In the United Kingdom this
announcement is directed exclusively at Qualified Investors (i) who
have professional experience in matters relating to investments
falling within Article 19(5) of the Financial Services and Markets
Act 2000 (Financial Promotion) Order 2005, as amended (the "Order")
or (ii) who fall within Article 49(2)(A) to (D) of the Order, and
(iii) to whom it may otherwise lawfully be communicated; any other
persons in the United Kingdom should not take any action on the
basis of this announcement and should not act on or rely on it.
This announcement is not an offer of securities or investments for
sale nor a solicitation of an offer to buy securities or
investments in any jurisdiction where such offer or solicitation
would be unlawful. No action has been taken that would permit an
offering of the securities or possession or distribution of this
announcement in any jurisdiction where action for that purpose is
required. Persons into whose possession this announcement comes are
required to inform themselves about and to observe any such
restrictions.
In connection with any offering of the shares of Banca
Farmafactoring S.p.A. (the "Shares"), the Sole Bookrunner and any
of its affiliates acting as an investor for its own account may
take up as a proprietary position any Shares and in that capacity,
may retain, purchase or sell for their own account such Shares. In
addition, the Sole Bookrunner or its affiliates may enter into
financing arrangements and swaps with investors in connection with
which the Sole Bookrunner (or its affiliates) may from time to time
acquire, hold or dispose of Shares. The Sole Bookrunner does not
intend to disclose the extent of any such investment or
transactions otherwise than in accordance with any legal or
regulatory obligation to do so.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEFBMBTMTIMTLM
(END) Dow Jones Newswires
June 02, 2020 02:00 ET (06:00 GMT)
